Tali Sahar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Tali Sahar has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Adi Shraibman
Department of Computer Science, The Academic College of Tel Aviv-Yaffo, Tel Aviv 69978, Israel
1 shared publication Ali Jalali
The Alan Edwards Pain Management Unit (AEPMU), McGill University Healthcare Center
1 shared publicationAmir Minerbi
Institute for Pain Medicine, Rambam Health Campus, and the Technion-Israel Institute of Technology
1 shared publicationAmnon Lahad
1 shared publication- Dan Ofer
Cancer Research Center and Wohl Institute of Translational Medicine, Sheba Medical Center, Tel Hashomer, Israel
1 shared publication Daniel Oluwafemi Odebiyi
1 shared publication
Latest Publications
- Open Access
Effects of the COVID-19 Pandemic on Individuals with Fibromyalgia – a Systematic Scoping Review Protocol
Objective The objectives of this review are to systematically search databases and identify studies that examined the effects of COVID-19 pandemic on symptomatology of adults who had fibromyalgia prior to the pandemic, in order to map the existing knowledge and identify knowledge gaps. Introduction The COVID-19 pandemic has affected people worldwide in multiple ways. Some suffered infection of varying severity and many experienced stressors associated with quarantine restrictions, lockdowns, and the consequences of social distancing. An initial literature search indicates that the pandemic had different and sometime contradicting effects on individuals with fibromyalgia; while some people experienced worsening of symptoms, others reported symptom relief because of the reduced pace and demands of daily life. Inclusion criteria Any studies that explored the experience of adults with fibromyalgia syndrome during the COVID-19 pandemic. We will review only studies with participants who were diagnosed with fibromyalgia prior to the pandemic. Methods Following a pilot search, we developed a full search strategy for Medline, Embase, CINAHL and PsycInfo. The reference list of all included sources of evidence will be screened for additional studies. Sources of unpublished studies to be searched: clinical trial.gov, OPENGREY.EU and MedRxiv. Studies in any language will be included. Abstracts will be screened for inclusion by two reviewers. Similarly, two independent reviewers will systematically extract the data from the included articles. Disagreements in any stage will be resolved through consensus. The results will be presented in tables and will be accompanied by a narrative analysis.
Open AccessEffects of the COVID-19 Pandemic on Individuals with Fibromyalgia – a Systematic Scoping Review Protocol
Objective The objectives of this review are to systematically search databases and identify studies that examined the effects of COVID-19 pandemic on symptomatology of adults who had fibromyalgia prior to the pandemic, in order to map the existing knowledge and identify knowledge gaps. Introduction The COVID-19 pandemic has affected people worldwide in multiple ways. Some suffered infection of varying severity and many experienced stressors associated with quarantine restrictions, lockdowns, and the consequences of social distancing. An initial literature search indicates that the pandemic had different and sometime contradicting effects on individuals with fibromyalgia; while some people experienced worsening of symptoms, others reported symptom relief because of the reduced pace and demands of daily life. Inclusion criteria Any studies that explored the experience of adults with fibromyalgia syndrome during the COVID-19 pandemic. We will review only studies with participants who were diagnosed with fibromyalgia prior to the pandemic. Methods Following a pilot search, we developed a full search strategy for Medline, Embase, CINAHL and PsycInfo. The reference list of all included sources of evidence will be screened for additional studies. Sources of unpublished studies to be searched: clinical trial.gov, OPENGREY.EU and MedRxiv. Studies in any language will be included. Abstracts will be screened for inclusion by two reviewers. Similarly, two independent reviewers will systematically extract the data from the included articles. Disagreements in any stage will be resolved through consensus. The results will be presented in tables and will be accompanied by a narrative analysis.
- Open Access
- 7 July 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (7) , 1114
Revisiting the Risk Factors for Endometriosis: A Machine Learning Approach
Endometriosis is a condition characterized by implants of endometrial tissues into extrauterine sites, mostly within the pelvic peritoneum. The prevalence of endometriosis is under-diagnosed and is estimated to account for 5–10% of all women of reproductive age. The goal of this study was to develop a model for endometriosis based on the UK-biobank (UKB) and re-assess the contribution of known risk factors to endometriosis. We partitioned the data into those diagnosed with endometriosis (5924; ICD-10: N80) and a control group (142,723). We included over 1000 variables from the UKB covering personal information about female health, lifestyle, self-reported data, genetic variants, and medical history prior to endometriosis diagnosis. We applied machine learning algorithms to train an endometriosis prediction model. The optimal prediction was achieved with the gradient boosting algorithms of CatBoost for the data-combined model with an area under the ROC curve (ROC-AUC) of 0.81. The same results were obtained for women from a mixed ethnicity population of the UKB (7112; ICD-10: N80). We discovered that, prior to being diagnosed with endometriosis, affected women had significantly more ICD-10 diagnoses than the average unaffected woman. We used SHAP, an explainable AI tool, to estimate the marginal impact of a feature, given all other features. The informative features ranked by SHAP values included irritable bowel syndrome (IBS) and the length of the menstrual cycle. We conclude that the rich population-based retrospective data from the UKB are valuable for developing unified machine learning endometriosis models despite the limitations of missing data, noisy medical input, and participant age. The informative features of the model may improve clinical utility for endometriosis diagnosis.
- 7 July 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (7) , 1114
Open AccessRevisiting the Risk Factors for Endometriosis: A Machine Learning Approach
Endometriosis is a condition characterized by implants of endometrial tissues into extrauterine sites, mostly within the pelvic peritoneum. The prevalence of endometriosis is under-diagnosed and is estimated to account for 5–10% of all women of reproductive age. The goal of this study was to develop a model for endometriosis based on the UK-biobank (UKB) and re-assess the contribution of known risk factors to endometriosis. We partitioned the data into those diagnosed with endometriosis (5924; ICD-10: N80) and a control group (142,723). We included over 1000 variables from the UKB covering personal information about female health, lifestyle, self-reported data, genetic variants, and medical history prior to endometriosis diagnosis. We applied machine learning algorithms to train an endometriosis prediction model. The optimal prediction was achieved with the gradient boosting algorithms of CatBoost for the data-combined model with an area under the ROC curve (ROC-AUC) of 0.81. The same results were obtained for women from a mixed ethnicity population of the UKB (7112; ICD-10: N80). We discovered that, prior to being diagnosed with endometriosis, affected women had significantly more ICD-10 diagnoses than the average unaffected woman. We used SHAP, an explainable AI tool, to estimate the marginal impact of a feature, given all other features. The informative features ranked by SHAP values included irritable bowel syndrome (IBS) and the length of the menstrual cycle. We conclude that the rich population-based retrospective data from the UKB are valuable for developing unified machine learning endometriosis models despite the limitations of missing data, noisy medical input, and participant age. The informative features of the model may improve clinical utility for endometriosis diagnosis.
- 1 April 2009
- Published by Wolters Kluwer Health in Spine
- Vol. 34 (9) , 924-933
Insoles for Prevention and Treatment of Back Pain
A systematic review of randomized controlled trials. To determine the effectiveness of shoe insoles in the prevention and treatment of nonspecific back pain compared with placebo, no intervention, or other interventions. There is lack of theoretical and clinical knowledge of the use of insoles for prevention or treatment of back pain. We searched electronic databases from inception to October 2008. We reviewed reference lists in review articles, guidelines, and in the included trials; conducted citation tracking; and contacted individuals with expertise in this domain. One review author conducted the searches and blinded the retrieved references for authors, institution, and journal. Two review authors independently selected the relevant articles. Two different review authors independently assessed the methodological quality and clinical relevance and extracted the data from each trial using the criteria recommended by the Cochrane Back Review Group. Six randomized controlled trials met inclusion criteria: 3 examined prevention of back pain (2061 participants) and 3 examined mixed populations (256 participants) without being clear whether they were aimed at primary or secondary prevention or treatment. No treatment trials were found. There is strong evidence that the use of insoles does not prevent back pain. There is limited evidence that insoles alleviate back pain or adversely shift the pain to the lower extremities. There is strong evidence that insoles are not effective for the prevention of back pain. The current evidence on insoles as treatment for low back pain does not allow any conclusions.
- 1 April 2009
- Published by Wolters Kluwer Health in Spine
- Vol. 34 (9) , 924-933
Insoles for Prevention and Treatment of Back Pain
A systematic review of randomized controlled trials. To determine the effectiveness of shoe insoles in the prevention and treatment of nonspecific back pain compared with placebo, no intervention, or other interventions. There is lack of theoretical and clinical knowledge of the use of insoles for prevention or treatment of back pain. We searched electronic databases from inception to October 2008. We reviewed reference lists in review articles, guidelines, and in the included trials; conducted citation tracking; and contacted individuals with expertise in this domain. One review author conducted the searches and blinded the retrieved references for authors, institution, and journal. Two review authors independently selected the relevant articles. Two different review authors independently assessed the methodological quality and clinical relevance and extracted the data from each trial using the criteria recommended by the Cochrane Back Review Group. Six randomized controlled trials met inclusion criteria: 3 examined prevention of back pain (2061 participants) and 3 examined mixed populations (256 participants) without being clear whether they were aimed at primary or secondary prevention or treatment. No treatment trials were found. There is strong evidence that the use of insoles does not prevent back pain. There is limited evidence that insoles alleviate back pain or adversely shift the pain to the lower extremities. There is strong evidence that insoles are not effective for the prevention of back pain. The current evidence on insoles as treatment for low back pain does not allow any conclusions.